全文获取类型
收费全文 | 13853篇 |
免费 | 1476篇 |
国内免费 | 39篇 |
专业分类
耳鼻咽喉 | 125篇 |
儿科学 | 392篇 |
妇产科学 | 374篇 |
基础医学 | 1751篇 |
口腔科学 | 264篇 |
临床医学 | 1479篇 |
内科学 | 3101篇 |
皮肤病学 | 116篇 |
神经病学 | 1079篇 |
特种医学 | 639篇 |
外国民族医学 | 1篇 |
外科学 | 1497篇 |
综合类 | 444篇 |
一般理论 | 10篇 |
预防医学 | 1786篇 |
眼科学 | 347篇 |
药学 | 1104篇 |
中国医学 | 17篇 |
肿瘤学 | 842篇 |
出版年
2021年 | 211篇 |
2020年 | 120篇 |
2019年 | 207篇 |
2018年 | 229篇 |
2017年 | 141篇 |
2016年 | 175篇 |
2015年 | 198篇 |
2014年 | 265篇 |
2013年 | 475篇 |
2012年 | 609篇 |
2011年 | 691篇 |
2010年 | 362篇 |
2009年 | 335篇 |
2008年 | 555篇 |
2007年 | 691篇 |
2006年 | 599篇 |
2005年 | 625篇 |
2004年 | 633篇 |
2003年 | 574篇 |
2002年 | 586篇 |
2001年 | 470篇 |
2000年 | 466篇 |
1999年 | 400篇 |
1998年 | 161篇 |
1997年 | 143篇 |
1996年 | 125篇 |
1995年 | 145篇 |
1994年 | 121篇 |
1992年 | 282篇 |
1991年 | 309篇 |
1990年 | 254篇 |
1989年 | 269篇 |
1988年 | 232篇 |
1987年 | 268篇 |
1986年 | 203篇 |
1985年 | 233篇 |
1984年 | 185篇 |
1983年 | 167篇 |
1982年 | 130篇 |
1981年 | 129篇 |
1979年 | 162篇 |
1978年 | 122篇 |
1977年 | 111篇 |
1976年 | 126篇 |
1975年 | 133篇 |
1974年 | 170篇 |
1973年 | 162篇 |
1972年 | 141篇 |
1971年 | 118篇 |
1969年 | 108篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
Sebastian Mondaca Walid K. Chatila David Bates Jaclyn F. Hechtman Andrea Cercek Neil H. Segal Zsofia K. Stadler Anna M. Varghese Ritika Kundra Marinela Capanu Jinru Shia Nikolaus Schultz Leonard Saltz Rona Yaeger 《Clinical colorectal cancer》2019,18(1):e39-e52
Background
Treatment of advanced anal squamous cell cancer (SCC) is usually with the combination of cisplatin and 5-fluorouracil, which is associated with heterogeneous responses across patients and significant toxicity. We examined the safety and efficacy of a modified schedule, FOLFCIS (leucovorin, fluorouracil, and cisplatin), and performed an integrated clinical and genomic analysis of anal SCC.Patients and Methods
We reviewed all patients with advanced anal SCC receiving first-line FOLFCIS chemotherapy – essentially a FOLFOX (leucovorin, fluorouracil, and oxaliplatin) schedule with cisplatin substituted for oxaliplatin – in our institution between 2007 and 2017, and performed deep sequencing to identify genomic markers of response and key genomic drivers.Results
Fifty-three patients with advanced anal SCC (48 metastatic; 5 unresectable, locally advanced) received first-line FOLFCIS during this period; all were platinum-naive. The response rate was 48% (95% confidence interval [CI], 32.6%-63%). With a median follow-up of 41.6 months, progression-free survival and overall survival were 7.1 months (95% CI, 4.4-8.6 months) and 22.1 months (95% CI, 16.9-28.1 months), respectively. Among all patients with advanced anal SCC that underwent sequencing during the study period, the most frequent genomic alterations consisted of chromosome 3q amplification (51%) and mutations in PIK3CA (29%) and KMT2D (22%). No genomic alteration correlated with response to platinum-containing treatment. Although there were few cases, patients with human papillomavirus-negative anal SCC did not appear to benefit from FOLFCIS, and all harbored distinct genomic profiles with TP53, TERT promoter, and CDKN2A mutations.Conclusions
FOLFCIS appears effective and safe as first-line chemotherapy in patients with advanced anal SCC and represents an alternative treatment option for these patients. 相似文献4.
5.
Gerald T Voelbel Marsha E Bates Jennifer F Buckman Gahan Pandina Robert L Hendren 《Neuropsychopharmacology》2006,60(9):942-950
BACKGROUND: Impaired neuropsychological test performance, especially on tests of executive function and attention, is often seen in children diagnosed with autism spectrum disorders (ASD). Structures involved in fronto-striatal circuitry, such as the caudate nucleus, may support these cognitive abilities. However, few studies have examined caudate volumes specifically in children with ASD, or correlated caudate volumes to cognitive ability. METHODS: Neuropsychological test scores and caudate volumes of children with ASD were compared to those of children with bipolar disorder (BD) and of typically developing (TD) children. The relationship between test performance and caudate volumes was analyzed. RESULTS: The ASD group displayed larger right and left caudate volumes, and modest executive deficits, compared to TD controls. While caudate volume inversely predicted performance on the Wisconsin Card Sorting Test in all participants, it differentially predicted performance on measures of attention across the ASD, BD and TD groups. CONCLUSIONS: Larger caudate volumes were related to impaired problem solving. On a test of attention, larger left caudate volumes predicted increased impulsivity and more omission errors in the ASD group as compared to the TD group, however smaller volume predicted poorer discriminant responding as compared to the BD group. 相似文献
6.
Mark S. Wallace Steven G. Charapata Robert Fisher Michael Byas‐Smith Peter S. Staats Martha Mayo Dawn McGuire David Ellis 《Neuromodulation》2006,9(2):75-86
Objective. The safety and efficacy of intrathecal (IT) ziconotide was studied in a randomized, double‐blind, placebo‐controlled trial. Materials and Methods. Patients (169 ziconotide, 86 placebo) with severe chronic nonmalignant pain unresponsive to conventional therapy and a visual analog scale of pain intensity (VASPI score) ≥ 50 mm were treated over a 6‐day period in an inpatient hospital setting. Initial starting dose was 0.4 µg/hour and was titrated to analgesia or intolerance (maximum dose 7.0 µg/hour). The starting and maximum doses were reduced to 0.1 µg/hour and 2.4 µg/hour, respectively, due to adverse events (AEs). Results. The mean percent reduction in VASPI score from baseline was 31.2% and 6.0% for ziconotide‐ and placebo‐treated patients, respectively (p ≤ 0.001). During the initial titration phase, a significantly greater percentage of patients in the ziconotide group compared to the placebo group reported AEs, including abnormal gait, amblyopia, dizziness, nausea, nystagmus, pain, urinary retention, and vomiting. Conclusion. Ziconotide provided significant analgesia in patients for whom conventional therapy failed. However, there was a considerable incidence of ziconotide‐associated AEs due to the rapid titration and high doses administered. 相似文献
7.
8.
9.
10.
The efficacy of radiology in evaluating dysphagia was studied in 86 patients by comparison to endoscopic findings. In the 66 patients with endoscopic abnormalities radiology was correct in 54, for a sensitivity of 82%. Sensitivity of radiology improved to 95% if mild esophagitis was excluded. In the 20 patients with normal endoscopy, radiology was normal in 18 (90%). Thus radiology proved to be a reliable means of evaluating the esophagus in patients with dysphagia. 相似文献